Effects of obesity and 10 weeks metformin treatment on liver steatosis

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease in adolescents and adults, and the risk of developing NAFLD increases with obesity. In the present study, it was shown that obesity increased fatty liver (steatosis) using an obese Zucker rat model. Metformin is an oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakkak, Reza, Rose, Shannon, Spray, Beverly, Kozaczek, Melisa, Korourian, Soheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042663/
https://www.ncbi.nlm.nih.gov/pubmed/33859820
http://dx.doi.org/10.3892/br.2021.1425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042663/
https://www.ncbi.nlm.nih.gov/pubmed/33859820
http://dx.doi.org/10.3892/br.2021.1425

Ejemplares similares